Interferon Therapy (HCV)

Patients with Thyroid Autoantibodies Are Candidates for IFN

Published in Hepatitis Weekly, September 27th, 1999

The presence of thyroid autoantibodies does not contraindicate interferon therapy in patients with chronic hepatitis C, according to a study from Taiwan.

In this study, M.J. Huang and colleagues sought to clarify controversies on the prevalence and clinical significance of thyroid autoimmunity in hepatitis C virus (HCV) infection by conducting a prospective controlled and follow-up study ("Prevalence and Significance of Thyroid Autoantibodies in Patients with Chronic Hepatitis C Virus Infection," Clin Endocrinol, 1999;50(4):503-509).

Serum thyroid microsomal antibody (TMA) and thyroid-stimulating hormone were assayed and compared in a consecutive,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1999-09-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry